Max Healthcare Institute Limited
NSE: MAXHEALTH BSE: MAXHEALTH
Prev Close
1274.3
Open Price
1275.2
Volume
875,316
Today Low / High
1253 / 1276.7
52 WK Low / High
836.6 / 1314.3
Range
1,201 - 1,328
Prev Close
1273.9
Open Price
1273.9
Volume
16,937
Today Low / High
1253.2 / 1276.2
52 WK Low / High
837 / 1314.3
Range
1,202 - 1,328
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1264.6 (target range: 1,201 - 1,328), reflecting a change of -9.7 (-0.7612%). On the BSE, it is listed at 1265 (target range: 1,202 - 1,328), showing a change of -8.9 (-0.69864%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Max Healthcare Institute Limited Graph
Max Healthcare Institute Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Max Healthcare Institute Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,264.60, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 1,265.00 | 1,277.65 | 1,149.89 - 1,405.42 |
1,290.30 | 1,032.24 - 1,548.36 | ||
1,302.95 | 912.07 - 1,693.84 | ||
Bearish Scenario | 1,265.00 | 1,252.35 | 1,127.12 - 1,377.59 |
1,239.70 | 991.76 - 1,487.64 | ||
1,227.05 | 858.94 - 1,595.17 |
Overview of Max Healthcare Institute Limited
ISIN
INE027H01010
Industry
Medical - Care Facilities
Vol.Avg
2,066,586
Market Cap
1,229,377,096,200
Last Dividend
3
Official Website
IPO Date
2020-08-21
DCF Diff
-71.82
DCF
1,331
Financial Ratios Every Investor Needs
Stock Dividend of MAXHEALTH
Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|---|
2025-07-04 | July 04, 25 | 1.5 | 1.5 | 2025-07-04 | 2025-08-29 | |
2024-08-23 | August 23, 24 | 1.5 | 1.5 | 2024-08-23 | 2024-10-20 | |
2023-09-08 | September 08, 23 | 1 | 1 | 2023-09-08 | 2023-10-27 |
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 7,028.46 Cr | 2,651.06 Cr | 4,377.40 Cr | 0.6228 | 0.00 Cr | 1,474.70 Cr | 2,902.70 Cr | 1,075.88 Cr | 11.07 | 1,800.53 Cr | 0.1531 |
2024-03-31 | 5,406.02 Cr | 2,052.92 Cr | 3,353.10 Cr | 0.6203 | 0.51 Cr | 1,116.89 Cr | 2,235.70 Cr | 1,057.64 Cr | 10.89 | 1,670.19 Cr | 0.1956 |
2023-03-31 | 4,562.60 Cr | 922.01 Cr | 3,640.59 Cr | 0.7979 | 0.36 Cr | 1,126.92 Cr | 1,024.02 Cr | 1,103.51 Cr | 11.38 | 1,379.77 Cr | 0.2419 |
2022-03-31 | 3,883.19 Cr | 922.90 Cr | 2,960.29 Cr | 0.7623 | -159.84 Cr | 908.19 Cr | 757.96 Cr | 605.05 Cr | 6.25 | 1,060.89 Cr | 0.1558 |
2021-03-31 | 2,482.41 Cr | 594.41 Cr | 1,888.00 Cr | 0.7606 | 0.00 Cr | 583.25 Cr | 243.05 Cr | -137.55 Cr | -1.59 | 284.90 Cr | -0.0554 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 681.89 Cr | 15,214.48 Cr | 5,833.61 Cr | 9,380.8700 Cr | 3,010.29 Cr | 2,328.40 Cr | 106.21 Cr | 6,362.38 Cr | 0.00 Cr | 0.00 Cr | 2.89 Cr | 1,813.7700 Cr |
2024-03-31 | 979.84 Cr | 11,999.94 Cr | 3,591.80 Cr | 8,408.1400 Cr | 1,507.89 Cr | 528.05 Cr | 79.84 Cr | 3,691.08 Cr | 49.15 Cr | 16.89 Cr | 2.12 Cr | 1,248.7100 Cr |
2023-03-31 | 42.75 Cr | 10,101.85 Cr | 2,692.26 Cr | 7,409.5900 Cr | 688.96 Cr | 646.21 Cr | 76.23 Cr | 2,225.63 Cr | 332.93 Cr | 11.73 Cr | 0.51 Cr | 1,045.5700 Cr |
2022-03-31 | 309.14 Cr | 9,189.13 Cr | 2,906.66 Cr | 6,282.4700 Cr | 1,132.67 Cr | 823.53 Cr | 61.36 Cr | 2,058.32 Cr | 118.84 Cr | 10.82 Cr | 2.02 Cr | 757.2700 Cr |
2021-03-31 | 626.59 Cr | 8,544.44 Cr | 2,905.76 Cr | 5,638.6800 Cr | 1,325.26 Cr | 698.67 Cr | 53.80 Cr | 1,774.91 Cr | 188.10 Cr | 11.41 Cr | 1.04 Cr | 776.9300 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 1,459.3100 Cr | -1,631.7400 Cr | -163.8000 Cr | 493.7800 Cr | -318.6000 Cr | 661.2400 Cr | -965.5300 Cr | 1,075.8800 Cr | 119.8700 Cr | -145.5800 Cr | -19.2000 Cr |
2024-03-31 | 1,121.8000 Cr | -1,285.4500 Cr | -263.7400 Cr | 343.0200 Cr | -394.4900 Cr | 979.8400 Cr | -778.7800 Cr | 1,057.6400 Cr | 78.1300 Cr | -97.0100 Cr | 5.9000 Cr |
2023-03-31 | 1,209.1800 Cr | -1,187.0100 Cr | -288.5600 Cr | 873.5700 Cr | -266.3900 Cr | 42.7500 Cr | -335.6100 Cr | 1,063.7200 Cr | -161.7600 Cr | 0.0000 Cr | -14.8700 Cr |
2022-03-31 | 748.4900 Cr | -771.7700 Cr | -294.1700 Cr | 187.1800 Cr | -317.4500 Cr | 309.1400 Cr | -561.3100 Cr | 738.9000 Cr | -227.1600 Cr | 0.0000 Cr | -7.5600 Cr |
2021-03-31 | 117.8600 Cr | -73.0000 Cr | 191.3300 Cr | -0.5600 Cr | 515.5800 Cr | 626.5900 Cr | -118.4200 Cr | -68.6500 Cr | -791.1200 Cr | 0.0000 Cr | 17.2500 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 1,909.74 Cr | 725.02 Cr | 1,184.72 Cr | 0.6204 | 778.38 Cr | 319.00 Cr | 3.28 | 488.58 Cr | 0.1670 |
2024-12-31 | 1,868.31 Cr | 391.82 Cr | 1,476.49 Cr | 0.7903 | 401.59 Cr | 238.80 Cr | 2.46 | 458.80 Cr | 0.1278 |
2024-09-30 | 1,707.46 Cr | 1,071.71 Cr | 635.75 Cr | 0.3723 | 366.39 Cr | 281.81 Cr | 2.90 | 491.38 Cr | 0.1650 |
2024-06-30 | 1,542.95 Cr | 1,001.18 Cr | 541.77 Cr | 0.3511 | 310.51 Cr | 236.27 Cr | 2.43 | 422.09 Cr | 0.1531 |
2024-03-31 | 1,422.90 Cr | 900.31 Cr | 522.59 Cr | 0.3673 | 311.21 Cr | 251.54 Cr | 2.59 | 426.78 Cr | 0.1768 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 681.89 Cr | 0.00 Cr | 681.89 Cr | 687.31 Cr | 106.21 Cr | 1,592.57 Cr | 6,362.38 Cr | 15,214.48 Cr | 5,833.61 Cr |
2024-12-31 | 0.00 Cr | 0.00 Cr | 1,286.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -8,799.06 Cr |
2024-09-30 | 963.96 Cr | 322.35 Cr | 1,286.31 Cr | 528.69 Cr | 93.42 Cr | 1,980.76 Cr | 4,507.20 Cr | 13,126.87 Cr | 4,327.81 Cr |
2024-06-30 | -1,099.27 Cr | 2,198.54 Cr | 1,099.27 Cr | 0.00 Cr | 0.00 Cr | 1,099.27 Cr | 0.00 Cr | 0.00 Cr | -8,408.14 Cr |
2024-03-31 | 1,099.27 Cr | 160.77 Cr | 1,099.27 Cr | 496.65 Cr | 79.84 Cr | 1,706.18 Cr | 3,691.08 Cr | 11,999.94 Cr | 3,591.80 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 319.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-12-31 | 238.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-09-30 | 281.81 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-06-30 | 236.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-03-31 | 251.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
No split history data available. |
Similar Stocks: Medical - Care Facilities
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
Max Healthcare Institute Limited | MAXHEALTH | ₹1,264.60 | ₹1,229,377,096,200.00 | ₹875,316.00 |
Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,450.00 | ₹1,071,198,250,000.00 | ₹266,672.00 |
Fortis Healthcare Limited | FORTIS | ₹842.70 | ₹636,203,106,600.00 | ₹1,418,534.00 |
Narayana Hrudayalaya Limited | NH | ₹1,937.80 | ₹396,010,745,800.00 | ₹180,837.00 |
Global Health Limited | MEDANTA | ₹1,306.30 | ₹350,951,041,331.00 | ₹168,490.00 |
Aster DM Healthcare Limited | ASTERDM | ₹592.75 | ₹307,116,222,750.00 | ₹338,589.00 |
Krishna Institute of Medical Sciences Limited | KIMS | ₹750.45 | ₹300,284,312,550.00 | ₹233,366.00 |
Rainbow Children's Medicare Limited | RAINBOW | ₹1,517.20 | ₹154,074,199,793.00 | ₹80,643.00 |
HealthCare Global Enterprises Limited | HCG | ₹618.25 | ₹86,193,323,750.00 | ₹461,073.00 |
Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹626.55 | ₹60,370,821,125.00 | ₹180,496.00 |
Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹477.15 | ₹43,741,771,950.00 | ₹256,398.00 |
Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Artemis Medicare Services Limited | ARTEMISMED | ₹239.80 | ₹33,308,220,000.00 | ₹66,856.00 |
Key Executives
Gender: Not Specified
Year Born: 1958
Gender: male
Year Born: 1965
Gender: Not Specified
Year Born: 1972
Gender: male
Year Born: 1978
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1973
Gender: Not Specified
Year Born: 1970
Gender: male
Year Born: 1973
FAQs about Max Healthcare Institute Limited
The CEO is Abhay Soi.
The current price is ₹1,264.60.
The range is ₹836.6-1314.3.
The market capitalization is ₹122,937.71 crores.
The dividend yield is 0.24%.
The P/E ratio is 115.02.
The company operates in the Healthcare sector.
Overview of Max Healthcare Institute Limited (ISIN: INE027H01010) is a leading Medical - Care Facilities in India. With a market capitalization of ₹122,937.71 crores and an average daily volume of 2,066,586 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹3.